Article information
Full text is only aviable in PDF
References
[1.]
W.N. Kernan, C.M. Viscoli, L.M. Brass, J.P. Broderick, T. Brott, E. Feldmann, et al.
Phenylpropanolamine and the risk of hemorrhagic stroke.
N Engl J Med, 343 (2000), pp. 1826-1832
[2.]
S.E. Nissen.
ADHD drugs and cardiovascular risk.
N Engl J Med, 354 (2006), pp. 1445-1448
[3.]
L.B. Morgenstern, C.M. Viscoli, W.N. Kernan, L.M. Brass, J.P. Broderick, E. Feldmann, et al.
Use of ephedra-containing products and risk for hemorrhagic stroke.
Neurology, 60 (2003), pp. 132-135
[4.]
G.K. Call, M.C. Fleming, S. Sealfon, H. Levine, J.P. Kistler, C.M. Fisher.
Reversible cerebral segmental vasoconstriction.
Stroke, 19 (1988), pp. 1159-1170
[5.]
A.B. Singhal.
Cerebral vasoconstriction syndromes.
Top Stroke Rehabil, 11 (2004), pp. 1-6
[6.]
A.B. Singhal, W.J. Koroshetz, L.R. Caplan.
Cerebral vasoconstriction syndromes.
Uncommon causes of stroke, pp. 114-123
Copyright © 2010. Sociedad Española de Neurología
